Windtree Therapeutics, Inc. (WINT) Earnings History
Net Loss30 years of earnings data (1995–2024) · Currently unprofitable on a TTM basis
Loading earnings history...
Windtree Therapeutics, Inc. (WINT) Earnings Overview
As of June 28, 2026, Windtree Therapeutics, Inc. (WINT) reported trailing twelve-month net income of -$40M, reflecting +97.8% year-over-year growth. The company earned $-1499.64 per diluted share over the past four quarters.
Looking at the long-term picture, WINT's historical earnings data spans multiple years. The company achieved its highest annual net income of -$2M in fiscal 1996.
Windtree Therapeutics, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including CRVS (-$44M net income), NKTR (-$158M net income, -297.1% margin), AGIO (-$423M net income, -764.0% margin), WINT has comparable earnings metrics. Compare WINT vs CRVS →
WINT Earnings vs Peers
Earnings metrics vs comparable public companies
WINT Historical Earnings Data (1995–2024)
30 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | -$5M | +73.0% | -$25M | $-104.35 | - | - |
| 2023 | -$20M | +48.2% | -$18M | $-4711.54 | - | - |
| 2022 | -$39M | +42.0% | -$41M | $-56011.00 | - | - |
| 2021 | -$68M | -123.4% | -$77M | $-122924.00 | - | - |
| 2020 | -$30M | -10.2% | -$30M | $-93616.00 | - | - |
| 2019 | -$27M | -33.8% | -$25M | $-113138.00 | -13876.3% | -12572.2% |
| 2018 | -$21M | -11.3% | -$16M | $-999999.00 | -1148.4% | -905.8% |
| 2017 | -$18M | +53.3% | -$23M | $-999999.00 | -1242.2% | -1518.4% |
| 2016 | -$39M | +28.4% | -$38M | $-999999.00 | -1933.9% | -1862.7% |
| 2015 | -$55M | -25.2% | -$40M | $-999999.00 | -5589.7% | -4035.9% |
| 2014 | -$44M | +2.6% | -$43M | $-999999.00 | -1554.1% | -1525.9% |
| 2013 | -$45M | -21.2% | -$45M | $-999999.00 | -11653.4% | -11471.1% |
| 2012 | -$37M | -78.0% | -$38M | $-999999.00 | -19135.9% | -19394.4% |
| 2011 | -$21M | -9.3% | -$25M | $-999999.00 | -3602.2% | -4211.7% |
| 2010 | -$19M | +36.6% | -$26M | $-999999.00 | - | - |
| 2009 | -$30M | +22.7% | -$29M | $-999999.00 | - | - |
| 2008 | -$39M | +2.2% | -$38M | $-999999.00 | -850.1% | -834.7% |
| 2007 | -$40M | +13.7% | -$40M | $-999999.00 | - | - |
| 2006 | -$46M | +21.3% | -$47M | $-999999.00 | - | - |
| 2005 | -$59M | -27.5% | -$59M | $-999999.00 | -43958.2% | -44250.0% |
| 2004 | -$46M | -90.3% | -$46M | $-999999.00 | -3821.6% | -3807.4% |
| 2003 | -$24M | -39.2% | -$24M | $-7247.76 | -2341.4% | -2356.3% |
| 2002 | -$17M | -56.5% | -$18M | $-6708.85 | -978.8% | -1011.4% |
| 2001 | -$11M | -2.6% | -$12M | $-5573.00 | -1002.3% | -1075.7% |
| 2000 | -$11M | -119.1% | -$12M | $-6582.42 | -1465.7% | -1605.7% |
| 1999 | -$5M | +68.2% | -$5M | $-6610.67 | -2785.4% | -2871.9% |
| 1998 | -$16M | -69.6% | -$8M | $-52000.00 | -15600.0% | -7800.0% |
| 1997 | -$9M | -300.0% | -$9M | $-184000.00 | -1314.3% | -1314.3% |
| 1996 | -$2M | +17.9% | -$2M | $-46000.00 | -1150.0% | -1150.0% |
| 1995 | -$3M | - | -$2M | $-56000.00 | -2800.0% | -2400.0% |
Download Data
Export WINT earnings history in CSV or JSON format
Free sign-in required to download data
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
31+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
WINT — Frequently Asked Questions
Quick answers to the most common questions about buying WINT stock.
What is WINT earnings per share (EPS)?
WINT trailing twelve-month (TTM) diluted EPS is $-1499.64, reflecting +97.8% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 1995 to 2024 is available in the table on this page.
What is Windtree Therapeutics, Inc.'s net income?
Windtree Therapeutics, Inc. (WINT) trailing twelve-month net income is $-40M as of 2024. Earnings grew +97.8% year-over-year.
Is WINT profitable?
WINT is not currently profitable on a TTM basis, reporting a net loss of $-40M. Net margin is N/A. Investors should monitor for a return to profitability.
What is WINT's earnings growth rate?
WINT compound annual EPS growth rates (CAGR): 1-Year: N/A, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 1995 to 2024.
What are WINT's profit margins?
Windtree Therapeutics, Inc. net profit margin is N/A, operating margin is N/A, and gross margin is N/A. Below-average margins reflect competitive or cost pressures. Return on Equity is -82.0%.
Is WINT growing earnings?
Yes, WINT earnings are accelerating — EPS growth of +97.8% exceeds the 5-year CAGR of N/A. TTM net income reached $-40M. Earnings momentum is strengthening.
What was WINT's best earnings year?
Windtree Therapeutics, Inc.'s highest annual net income on record is $-2M, achieved in fiscal year 1996. Earnings history on this page spans 1995 to 2024 and includes all annual and quarterly figures.
What were WINT's earnings last quarter?
WINT's most recent reported quarter was Q3 2025. Net income was $-28M with diluted EPS of $-1.08. For a full breakdown of all quarters, see the quarterly earnings table on this page.